The US Food and Drug Administration (FDA) has chosen IBM, Merck, KPMG and...
- FDA chooses IBM, KMPG, Merck and Walmart for pharma blockchain pilot
- Antimicrobial resistance: sewage samples reveal bad sanitation as a key driver
- Inside the UK’s first vaccines innovation centre
- Inside Italy’s pharmaceutical industry
- RUNLABS: empowering life science through flexible working environments
FDA chooses IBM, KMPG, Merck and Walmart for pharma blockchain pilot
The US Food and Drug Administration (FDA) has chosen IBM, Merck, KPMG and Walmart to support its latest Drug Supply Chain Security Act (DSCSA) pilot programme, which focuses on blockchain interoperability.
Novartis denies physicians’ reports of Mayzent launch delays
A Novartis spokesperson said there are no known access delays to patients who are prescribed Mayzent, and many patients have already initiated the onboarding to Mayzent efficiently.
Antimicrobial resistance: sewage samples reveal bad sanitation as a key driver
Sequencing genes from DNA found in sewage has led to the conclusion that AMR prevalence is related to sanitation and general health outcomes, rather than use of antibiotics. How can this discovery and the creation of a global surveillance system support the fight against the spread of AMR and disease-causing microorganisms?
Inside the UK’s first vaccines innovation centre
A new, state-of-the-art Vaccines Manufacturing Innovation Centre (VMIC) was recently announced to address what is being called a structural gap in late-stage vaccine manufacturing in the UK. How will the plans improve emergency preparedness for epidemic threats?
International Dangerous Goods Logistics
These guiding principles are considered as ME Logistics' company strategy and forms the focus of its thinking and acting in regards to customer orientation and cooperation.
RUNLABS: empowering life science through flexible working environments
To enable researchers to concentrate purely on their work, RUNLABS takes over the other time-consuming tasks required to work in the life sciences. Allie Nawrat talks to CEO Steven Marcus about how a more flexible working environment makes science easier and facilitates collaboration.
$4.3m donated to PATH’s Visualise No Malaria scheme
At a World Malaria Day event in Paris, four technology companies have announced they will contribute $4.3m in technical support to healthcare non-profit PATH’s Visualise No Malaria project. The companies in question are Tableau, Mapbox, Exasol and Alteryx.
Zipline’s drone delivery of medical products expanded into Ghana
The Ghanaian Government and California-based automatic logistics company Zipline have launched a drone delivery network to distribute 148 priority products, including vaccines, blood products and medications, on demand to patients across Ghana.
Snake venom in pharma: access to antivenom is a topic that needs attention
Over 100,000 people die each year as a result of snake bites, but access to antivenom is often a challenging task thanks to manufacturers dropping antivenom products from their production line. Abi Millar finds out how this problem is being addressed.
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.